Abbonarsi

Factors associated with screening for glucose abnormalities after gestational diabetes mellitus: Baseline cohort of the interventional IMPACT study - 16/04/14

Doi : 10.1016/j.diabet.2013.12.002 
H. Bihan a, b, , E. Cosson b, c, C. Khiter d, L. Vittaz e, F. Faghfouri c, D. Leboeuf f, L. Carbillon g, H. Dauphin h, G. Reach a, P. Valensi c
a AP–HP, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Diabetology, Metabolic Diseases, CRNH-IdF, CINFO, Bobigny, France 
b Sorbonne Paris Cité, UMR U557 Inserm/U1125 Inra/Cnam/Université Paris 13, Bobigny, France 
c AP–HP, Jean-Verdier Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Endocrinology-Diabetology-Nutrition, CRNH-IdF, CINFO, Bondy, France 
d De La Fontaine Hospital, Department of Obstetrics and Gynecology, Saint-Denis, France 
e Ballanger Hospital, Department of Endocrinology-Diabetology, Aulnay-Sous-Bois, France 
f Seine-Saint-Denis Private Hospital, Department of Obstetrics and Gynecology, Le Blanc Mesnil, France 
g AP–HP, Jean-Verdier Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Gynaecology-Obstetrics, Bondy, France 
h Ballanger Hospital, Department of Gynecology, Aulnay-Sous-Bois, France 

Corresponding author. Department of Endocrinology, Diabetology and Metabolic diseases, Avicenne Hospital, 125, route de Stalingrad, 93009 Bobigny cedex, France. Tel.: +33 1 48 95 51 51; fax: +33 1 48 95 55 60.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Introduction

Although it is important to screen women who have had gestational diabetes mellitus (GDM) for abnormal post-partum glucose levels, such testing is rarely performed. The aim of this study was to use data from the first observational phase of the IMPACT study to determine rates of screening within 6 months of delivery in a multiethnic cohort, focusing in particular on the effects of social deprivation and the risk of future diabetes.

Patients and methods

To investigate the frequency of post-partum screening, charts were analyzed, and all women attending four centres located in a deprived area who had had GDM between January 2009 and December 2010 were contacted by phone. The Evaluation of Precarity and Inequalities in Health Examination Centres (EPICES) deprivation index and Finnish Diabetes Risk Score (FINDRISK) questionnaire were also evaluated.

Results

Data were evaluable for 589 of the 719 women contacted (mean age: 33.4±5.2years; mean body mass index: 27.6±5.4kg/m2), and 196 (33.3%) reported having been screened. On multivariate analysis, factors associated with a lack of screening were smoking [odds ratio (OR): 0.42 (0.20–0.90), P<0.05], low consumption of fruit and vegetables [OR: 0.58 (0.39–0.82), P<0.01] and heavier offspring birth weight (P<0.05), although there were no differences in FINDRISK and EPICES scores between screened and unscreened women.

Conclusion

One-third of women who had had GDM reported having been screened for dysglycaemia at 6 months post-partum. However, it is expected that the interventional phase of the IMPACT study will increase screening rates, especially in women with the risk factors associated with lower screening rates during this observational phase.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Gestational diabetes mellitus, Screening test, Glucose abnormalities, Social deprivation


Mappa


© 2014  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 40 - N° 2

P. 151-157 - aprile 2014 Ritorno al numero
Articolo precedente Articolo precedente
  • Type 2 diabetes prevalence, health status and quality of care among the North African immigrant population living in France
  • S. Fosse-Edorh, A. Fagot-Campagna, B. Detournay, H. Bihan, A. Gautier, M. Dalichampt, C. Druet
| Articolo seguente Articolo seguente
  • Acute caloric restriction improves glomerular filtration rate in patients with morbid obesity and type 2 diabetes
  • I. Giordani, I. Malandrucco, S. Donno, F. Picconi, P. Di Giacinto, A. Di Flaviani, L. Chioma, S. Frontoni

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.